Lupin Ltd. (LUPIN)
BSE
Real-time Data
03:45 AM
Day's Range
2,181.0052 wk Range
1,881.80Overview - LUPIN - Lupin Ltd.
Key Statistics
Valuation
Enterprise Value
1.01T
P/E (Trailing)
‪23.23‬
P/E (Forward)
‪24.31‬
PEG Ratio
‪24.31‬
Price / Sales (TTM)
‪4.04‬
Price / Book
‪5.10‬
EV / EBITDA
‪16.67‬
Profitability
Gross Margin
‪74.57%‬
Profit Margin
‪17.47%‬
Operating Margin
‪25.83%‬
Return on Assets
‪10.75%‬
Return on Equity
‪24.52%‬
Ownership
Shares Outstanding
456.96M
Float
241.81M
Held by Insiders
‪47.04%‬
Held by Institutions
‪31.71%‬
Price stats
Beta
‪0.29‬
50-Day Avg
‪2,122.03‬
200-Day Avg
‪2,010.88‬
Dividends
Payout Ratio
‪12.71%‬
Frequency
Annual
Analyst Consensus
37 analysts
Market Cap - LUPIN - Lupin Ltd.
Peers - LUPIN - Lupin Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.
- LUPINBSELupin Ltd.1.00TMarket Cap+10.42%52-week change23.24P/E (Trailing)‪17.47%‬Profit Margin
- DIVISLABBSEDivi's Laboratories Ltd.2.25TMarket Cap+27.45%52-week change87.72P/E (Trailing)‪26.04%‬Profit Margin
- CIPLABSECipla Ltd.1.14TMarket Cap-11.64%52-week change25.39P/E (Trailing)‪16.25%‬Profit Margin
- LAURUSLABSBSELaurus Labs Ltd.1.00TMarket Cap+54.36%52-week change89.19P/E (Trailing)‪15.04%‬Profit Margin
- DRREDDYBSEDr. Reddy's Laboratories Ltd.994.50BMarket Cap-6.92%52-week change17.61P/E (Trailing)‪16.36%‬Profit Margin
- MANKINDBSEMankind Pharma Ltd.977.56BMarket Cap-2.49%52-week change48.14P/E (Trailing)‪13.85%‬Profit Margin
- AUROPHARMABSEAurobindo Pharma Ltd.936.28BMarket Cap+35.16%52-week change27.51P/E (Trailing)‪10.52%‬Profit Margin
Profile Summary - LUPIN - Lupin Ltd.
About
Lupin Ltd. is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of branded and generic formulations, as well as active pharmaceutical ingredients (APIs). The company focuses on the cardiovascular, anti-asthma, anti-diabetic, CNS, and anti-infective…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
